Ph.D. from the University of Louisville, USA, completed postdoctoral training at Yale University, USA, and earned an EMBA from Peking University.
With a strong background in medicinal chemistry, specializing in small molecule and peptide therapeutics.
Over 25 years of R&D and management experience in the biopharmaceutical industry, including more than 10 years as a founding CEO. Founded several biotech companies such as Keshine Pharmaceuticals and Suntech Biologics. Well-versed in capital markets, with hands-on experience leading a company to a successful IPO on the Nasdaq.
Responsible R&D, corporate management, financing, and business development (BD).